Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022

Author's Avatar
Nov 02, 2022

%3Cb%3ELucid+Diagnostics+Inc.%3C%2Fb%3E (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, a majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ), today announced that the Company will host a business update conference call and webcast on Monday, November 14, 2022, at 4:30 PM EDT. During the call, Lishan+Aklog%2C+M.D., Chairman, and Chief Executive Officer, will provide a business update including an overview of the Company’s operations and its growth strategy. In addition, Dennis+McGrath, Lucid’s Chief Financial Officer, will discuss the Company’s third-quarter 2022 financial results.